価格表

在庫・価格 : 2026年04月06日 21時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TRAIL-R2, Rabbit-Poly
データシート
NB100-55744 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥108,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時32分 現在

Anti-TRAIL-R2, Rabbit-Poly

  • 商品コード:NB100-55744
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥108,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Georgakis GV et al. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death.
Georgakis GV et al
2005/01/01
PubMed
2 Zou W et al. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res. 2004 Oct;
Zou W et al
2004/01/01
PubMed
3 Abdelrahim M et al. 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006 Apr;27(4):717-28
Abdelrahim M et al
2006/01/01
PubMed
4 Fan QL et al. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo. Cancer Chemother. Pharmacol. 2005 Feb;55(2):189-96
Fan QL et al
2005/01/01
PubMed
5 Burns TF et al. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 2001 Aug;20(34):4601-12
Burns TF et al
2001/01/01
PubMed
6 Wang S et al. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin. Cancer Res. 2010 May;16(9):2591-604
Wang S et al
2010/01/01
PubMed
7 Kim K et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin. Cancer Res. 2000 Feb;6(2):335-46
Kim K et al
2000/01/01
PubMed
8 Zhang HG et al. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver. J. Virol. 2002 Jun;76(11):5692-700
Zhang HG et al
2002/01/01
PubMed
9 Kandasamy K et al. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Cancer
Kandasamy K et al
2003/01/01
PubMed
10 Basile JR et al. The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J.
Basile JR et al
2001/01/01
PubMed
11 Cuello M et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res. 2001 Jun;61(
Cuello M et al
2001/01/01
PubMed
12 Jin Z et al. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J. Biol. Chem. 2004 Aug;279(34):35829-39
Jin Z et al
2004/01/01
PubMed
13 Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J. Gastroenterol. Hepatol. 2003 Jul;
Koyama S
2003/01/01
PubMed
14 Koyama S et al. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J. Cancer Res. Clin. Oncol. 2002 Feb;128(2):73-9
Koyama S et al
2002/01/01
PubMed
15 Dandrea T et al. The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic. Biol. Med. 2004 Apr;36(7):881-96
Dandrea T et al
2004/01/01
PubMed
16 Kim K et al. Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9. Cell Death Differ. 2004 May;11(5):583-7
Kim K et al
2004/01/01
PubMed
17 Eid MA et al. Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL). Mol. Cancer Ther. 2002 Aug;1(10):831-40
Eid MA et al
2002/01/01
PubMed
18 Younes M et al. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. Eur. J. Cancer 2006 Mar;42(4):542-7
Younes M et al
2006/01/01
PubMed
19 Xue M et al. Apoptosis is induced by docosahexaenoic acid in breast cancer cells via death receptor and mitochondria-mediated pathways. Mol Med Rep 2017 Jul;16(1):978-982
Xue M et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Georgakis GV et al. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death.
    Georgakis GV et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zou W et al. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res. 2004 Oct;
    Zou W et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Abdelrahim M et al. 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006 Apr;27(4):717-28
    Abdelrahim M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fan QL et al. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo. Cancer Chemother. Pharmacol. 2005 Feb;55(2):189-96
    Fan QL et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Burns TF et al. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 2001 Aug;20(34):4601-12
    Burns TF et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wang S et al. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin. Cancer Res. 2010 May;16(9):2591-604
    Wang S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kim K et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin. Cancer Res. 2000 Feb;6(2):335-46
    Kim K et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zhang HG et al. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver. J. Virol. 2002 Jun;76(11):5692-700
    Zhang HG et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Kandasamy K et al. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Cancer
    Kandasamy K et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Basile JR et al. The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J.
    Basile JR et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Cuello M et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res. 2001 Jun;61(
    Cuello M et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Jin Z et al. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J. Biol. Chem. 2004 Aug;279(34):35829-39
    Jin Z et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J. Gastroenterol. Hepatol. 2003 Jul;
    Koyama S
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Koyama S et al. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J. Cancer Res. Clin. Oncol. 2002 Feb;128(2):73-9
    Koyama S et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Dandrea T et al. The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic. Biol. Med. 2004 Apr;36(7):881-96
    Dandrea T et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kim K et al. Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9. Cell Death Differ. 2004 May;11(5):583-7
    Kim K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Eid MA et al. Mifepristone pretreatment overcomes resistance of prostate cancer cells to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL). Mol. Cancer Ther. 2002 Aug;1(10):831-40
    Eid MA et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Younes M et al. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. Eur. J. Cancer 2006 Mar;42(4):542-7
    Younes M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Xue M et al. Apoptosis is induced by docosahexaenoic acid in breast cancer cells via death receptor and mitochondria-mediated pathways. Mol Med Rep 2017 Jul;16(1):978-982
    Xue M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed